UBS raised the firm’s price target on Qualys (QLYS) to $150 from $145 and keeps a Neutral rating on the shares. Qualys’ Q3 was another positive step, featuring the third consecutive quarter of revenue growth acceleration and meaningful margin upside, though this was paired with a somewhat more mixed outlook for Q4, the analyst tells investors in a research note. The company seems more confident that execution around its ETM and ROC products is improving, but still sounds mixed on new logo growth and NRR is still hovering in the low-single-digit range, the firm says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QLYS:
- Balanced Outlook on Qualys: Growth Amid Uncertainties Leads to Hold Rating
- Qualys: Sustained Revenue Growth Amid Mixed Outlook and Valuation Concerns
- Qualys upgraded to Neutral from Underweight at Piper Sandler
- Balanced Outlook on Qualys: Strong Performance Amid Risks Justifies Hold Rating
- Qualys: Strong Q3 2025 Results Amid Competitive Challenges Justify Hold Rating